GRCE (Grace Therapeutics) Pangali Forward P/E

Logo grafis Grace Therapeutics, Inc. (GRCE)

Demand for rare disease therapies remains insulated from macroeconomic volatility, as evidenced by the forward P/E history of Grace Therapeutics, Inc. (GRCE). The value 0.00 describes the current status of the metric. FDA orphan drug status protects Grace Therapeutics, Inc. (GRCE) from price dumping. However, business success depends on clinical trial results and strict cost control of the R&D pipeline until the company achieves stable profitability.

GRCE - Prakiraan rega marang bathi Grace Therapeutics, Inc. ing rentang 29.10.2024 - 16.11.2026

Rincian metrik keuangan lan pasar Grace Therapeutics (GRCE)

- nilai saham lan prakiraan konsensus rega:
- indikator valuasi pasar bisnis:
Ringkesan analisis perusahaan:Grace Therapeutics, Inc.
Sampel barang gracetx.com

Grace Therapeutics, Inc. (GRCE) is developing a closed ecosystem for the therapy of rare CNS pathologies, protected by FDA orphan drug status. By analyzing the company's consensus P/E forecast, an investor assesses the ratio of the current price to expected earnings, which, under tight Fed policy, determines the business's ability to monetize innovations; meanwhile, low indicator values signal that the asset is undervalued, while extreme peaks indicate correction risks.

Pesaing langsung

Pangali Forward P/E BIIB|NBIX - Rasio prakiraan rega marang bathi|Pangali Forward P/E RGC (Regencell Bioscience Ltd)|Kapitalisasi marang proyeksi bathi axsome.com (AXSM)|ACADIA Pharmaceuticals Inc - Pangali Forward P/E|Rasio prakiraan rega marang bathi Xenon Pharmaceuticals Inc.|Viking Therapeutics (VKTX) - Rega marang bathi mangsa ngarep|Supernus Corp - Pangali mangsa ngarep rega marang bathi|Prakiraan rega marang bathi CPRX|Denali Therapeutics Inc. (DNLI) - Kapitalisasi marang proyeksi bathi|Prakiraan rega marang bathi HRMY (Harmony Corp)|BHVN - Rasio prakiraan rega marang bathi|Rega marang bathi mangsa ngarep Amylyx Pharmaceuticals, Inc. AMLX|Pangali mangsa ngarep rega marang bathi TRVI|PRAX - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi Anavex Life Sciences AVXL|CBLL: Pangali Forward P/E|Prakiraan rega marang bathi Prothena Corporation PLC|ALEC (alector.com) - Pangali Forward P/E|Prakiraan rega marang bathi Annexon, Inc. (ANNX)|Rega marang bathi mangsa ngarep Omeros Corporation (OMER)|Neurogene Inc. - Rasio rega marang bathi mangsa ngarep|acimmune.com - Prakiraan rega marang bathi|Pangali Forward P/E Voyager Therapeutics Inc VYGR|NMRA - Rega marang bathi mangsa ngarep|Pangali forward rega marang bathi Scilex Holding Company (SCLX)|Tevogen Bio Holdings (TVGN) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep ACOG|Rega marang bathi mangsa ngarep Cognition Therapeutics, Inc.|Inhibikase Therapeutics, Inc. - Rasio rega marang bathi sing dikarepake|Prakiraan rega marang bathi SAVA (Cassava)|Kapitalisasi marang proyeksi bathi Assertio Therapeutics|Coya Therapeutics, Inc. - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep VTGN (VistaGen Therapeutics Inc)|Ovid Therapeutics Inc - Pangali Forward P/E|Acumen Pharmaceuticals, Inc. (ABOS) - Prakiraan rega marang bathi|CRVO (CervoMed, Inc.) - Prakiraan rega marang bathi|Prakiraan rega marang bathi Alterity Therapeutics Ltd|Rega marang bathi mangsa ngarep Clene Inc.|PepGen Inc. - Rasio rega marang bathi sing dikarepake|Prakiraan rega marang bathi JUNS (Jupiter Neurosciences Inc)|Rega marang bathi mangsa ngarep RLMD (Relmada Therapeutics Inc)|Annovis Bio Inc - Prakiraan rega marang bathi|AIFF: Rasio rega marang bathi mangsa ngarep|Klotho Neurosciences - Pangali Forward P/E|NRSN (NeuroSense Therapeutics Ltd.) - Rasio rega marang bathi mangsa ngarep|Reviva Pharmaceuticals (RVPH) - Rega marang bathi mangsa ngarep|MTVA (MetaVia Inc.) - Rega marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep NeurAxis, Inc|Rega marang bathi mangsa ngarep HSDT|Pangali Forward P/E PASG|Kapitalisasi marang proyeksi bathi Neuphoria Therapeutics, Inc.|minervaneurosciences.com - Prakiraan rega marang bathi|Pangali Forward P/E Athira ATHA|Addex Therapeutics - Pangali Forward P/E|ALZN - Pangali Forward P/E|Cyclerion (CYCN) - Rega marang bathi mangsa ngarep|Protagenic (PTIX) - Pangali Forward P/E|Rega marang bathi mangsa ngarep Pasithea|Rasio rega marang bathi mangsa ngarep CRGT (Cortigent)|Rega marang bathi mangsa ngarep Avenue Therapeutics (ATXI)|BCLI - Rasio prakiraan rega marang bathi|Pangali Forward P/E CARA (Cara Therapeutics Inc)|CHRO - Prakiraan rega marang bathi|ELYM: Prakiraan rega marang bathi|Kapitalisasi marang proyeksi bathi Intra-Cellular Therapies, Inc. ITCI|Longboard Pharma (LBPH) - Rega marang bathi mangsa ngarep|Marinus - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep NKGen Biotech Inc|NRBO: Pangali mangsa ngarep rega marang bathi|Prakiraan rega marang bathi SAGE (Sage Therapeutics, Inc.)|Kapitalisasi marang proyeksi bathi Neurotrope|Rega marang bathi mangsa ngarep Trevena, Inc. TRVN|Vigil Neuroscience (VIGL) - Rasio prakiraan rega marang bathi|WENA: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi CERE (Cerevel Therapeutics)